Harvard Bioscience (HBIO) Current Leases (2019 - 2025)
Historic Current Leases for Harvard Bioscience (HBIO) over the last 7 years, with Q3 2025 value amounting to $1.5 million.
- Harvard Bioscience's Current Leases rose 3185.45% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 3185.45%. This contributed to the annual value of $1.2 million for FY2024, which is 1822.03% down from last year.
- According to the latest figures from Q3 2025, Harvard Bioscience's Current Leases is $1.5 million, which was up 3185.45% from $1.5 million recorded in Q2 2025.
- Over the past 5 years, Harvard Bioscience's Current Leases peaked at $2.2 million during Q1 2022, and registered a low of $1.1 million during Q2 2024.
- For the 5-year period, Harvard Bioscience's Current Leases averaged around $1.8 million, with its median value being $2.1 million (2021).
- Its Current Leases has fluctuated over the past 5 years, first tumbled by 5021.18% in 2024, then skyrocketed by 3733.46% in 2025.
- Quarter analysis of 5 years shows Harvard Bioscience's Current Leases stood at $2.1 million in 2021, then dropped by 0.33% to $2.1 million in 2022, then tumbled by 33.68% to $1.4 million in 2023, then decreased by 18.22% to $1.2 million in 2024, then rose by 28.32% to $1.5 million in 2025.
- Its Current Leases stands at $1.5 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.4 million for Q1 2025.